Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7731077

CCCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCNCC1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.44
EPHX1 P07099 1/20 0.41
CCR5 P51681 4/20 0.40
SLC6A4 P31645 5/20 0.39
SLC6A2 P23975 4/20 0.39
KCNJ1 P48048 1/20 0.39
KCNH2 Q12809 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
DCUN1D1 Q96GG9 1/20 0.37
KDM1A O60341 1/20 0.36
SLC2A1 P11166 1/20 0.36
CACNA1G O43497 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7732600 0.87 SLC6A4 (0.48) HTR2ACCR5SLC6A4SLC6A2KCNH2
Trifluoroacetic Acid SCHEMBL7723374 0.86 EPHX1 (0.43) HTR2AEPHX1CCR5KCNJ1L3MBTL1
Hydrochloric Acid SCHEMBL7668700 0.84 HTR2A (0.48) HTR2AEPHX1CCR5SLC6A4SLC6A2
Trifluoroacetic Acid SCHEMBL7732700 0.83 CCR5 (0.50) HTR2ACCR5
SCHEMBL7731085 0.81 CCR5 (0.42) HTR2AEPHX1CCR5SLC6A2KCNH2
Hydrochloric Acid SCHEMBL7135396 0.79 SLC6A4 (0.52) HTR2ACCR5SLC6A4SLC6A2KCNH2
SCHEMBL13543037 0.78 CCR5 (0.50) CCR5SLC6A4SLC6A2KCNH2MEN1
Hydrochloric Acid SCHEMBL7664598 0.78 EPHX1 (0.48) HTR2AEPHX1CCR5L3MBTL1MEN1
Hydrochloric Acid SCHEMBL7131167 0.77 CCR5 (0.51) HTR2AEPHX1CCR5
SCHEMBL13543082 0.75 CCR5 (0.53) HTR2ACCR5SLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399619-B1 PREVENTION AND TREATMENT OF AIDS AND VIRAL INFECTION BY HIV MERCK & CO., INC. 2002-06-04 US disclosed